Sumitomo Mitsui Trust Holdings, Inc. 10x Genomics, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $138 Billion
- Q1 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 5,363,366 shares of TXG stock, worth $44.4 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
5,363,366
Previous 5,713,484
6.13%
Holding current value
$44.4 Million
Previous $82 Million
42.93%
% of portfolio
0.03%
Previous 0.06%
Shares
20 transactions
Others Institutions Holding TXG
# of Institutions
311Shares Held
95.5MCall Options Held
76.4KPut Options Held
132K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.9MShares$98.8 Million1.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$90.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$52.9 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.5.71MShares$47.3 Million0.92% of portfolio
-
Morgan Stanley New York, NY3.93MShares$32.5 Million0.0% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $786M
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...